OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment
Ying Zhou, Muhammad Asad Farooq, Iqra Ajmal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115740-115740
Open Access | Times Cited: 14
Ying Zhou, Muhammad Asad Farooq, Iqra Ajmal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115740-115740
Open Access | Times Cited: 14
Showing 14 citing articles:
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 24
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 24
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, et al.
Cells (2024) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, et al.
Cells (2024) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Chimeric Cytokine Receptor TGF-β RⅡ/IL-21R Improves CAR-NK Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Gastric Cancer
Yaojun Ren, Min Xue, Xinhui Hui, et al.
Pharmacological Research (2025) Vol. 212, pp. 107637-107637
Open Access
Yaojun Ren, Min Xue, Xinhui Hui, et al.
Pharmacological Research (2025) Vol. 212, pp. 107637-107637
Open Access
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
GPR132 regulates the function of NK cells through the Gαs/CSK/ZAP70/NF-κB signaling pathway as a potential immune checkpoint
Xinhui Hui, Min Xue, Yaojun Ren, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access
Xinhui Hui, Min Xue, Yaojun Ren, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access
Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer
Iqra Ajmal, Muhammad Asad Farooq, Yixin Duan, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3539-3557
Closed Access | Times Cited: 4
Iqra Ajmal, Muhammad Asad Farooq, Yixin Duan, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3539-3557
Closed Access | Times Cited: 4
A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma
Xinhui Hui, Muhammad Asad Farooq, Yiran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Xinhui Hui, Muhammad Asad Farooq, Yiran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers
Qingqing Zhang, Xiao Song, Junhong Liu, et al.
Oncology Reviews (2025) Vol. 19
Open Access
Qingqing Zhang, Xiao Song, Junhong Liu, et al.
Oncology Reviews (2025) Vol. 19
Open Access
shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer
Hongmei Zhang, Jie Yao, Iqra Ajmal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Hongmei Zhang, Jie Yao, Iqra Ajmal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: Mechanisms and therapeutic strategies
Kai Pan, Qiong Li, Zhikun Guo, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108760-108760
Closed Access | Times Cited: 3
Kai Pan, Qiong Li, Zhikun Guo, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108760-108760
Closed Access | Times Cited: 3
Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies
Zewei Cheng, Xiaohan Cui, Song Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117229-117229
Open Access | Times Cited: 1
Zewei Cheng, Xiaohan Cui, Song Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117229-117229
Open Access | Times Cited: 1
CAR T-cells for pediatric solid tumors: where to go from here?
Tina Trautmann, Natalia Yakobian, Rosa Nguyen
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1445-1461
Open Access
Tina Trautmann, Natalia Yakobian, Rosa Nguyen
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1445-1461
Open Access
Next frontier in cancer treatment: an iPSC supported CAR-T cell therapies
Tayyaba Sona
Asia-Pacific Journal of Oncology (2024)
Open Access
Tayyaba Sona
Asia-Pacific Journal of Oncology (2024)
Open Access
